1362819-44-0

Upstream product

• 60710-39-6 3-bromo-p-cresol 

Downstream Products

• 1362820-19-6 4-bromo-5-(4-morpholinylmethyl)-2-[(phenylmethyl)oxy]benzoic acid 
• 1362820-16-3 phenylmethyl 4-bromo-5-(4-morpholinylmethyl)-2-[(phenylmethyl)oxy]benzoate 
• 1362820-10-7 (4-fluorophenyl)methyl 2-{[(4-fluorophenyl)methyl]oxy}-4-(1-methyl-1H-pyrazol-4-yl)-5-(4-morpholinylcarbonyl)benzoate 
• 1362820-07-2 2-bromo-4-{[(4-fluorophenyl)methyl]oxy}-5-({[(4-fluorophenyl)methyl]oxy}carbonyl)benzoic acid 
• 1362819-66-6 methyl 2-{[(4-fluorophenyl)methyl]oxy}-4-(1-methyl-1H-pyrazol-4-yl)-5-(4-morpholinylmethyl)benzoate 
• 1362819-62-2 methyl 4-bromo-2-hydroxy-5-(4-morpholinylmethyl)benzoate 
• 1362819-59-7 methyl 2-(acetyloxy)-4-bromo-5-(bromomethyl)benzoate 
• 1362819-56-4 methyl 2-(acetyloxy)-4-bromo-5-methylbenzoate 
• 1362819-53-1 methyl 4-bromo-2-hydroxy-5-methylbenzoate 
• 1362819-50-8 4-bromo-2-hydroxy-5-methylbenzoic acid 
• 1362819-47-3 4-bromo-5-methyl-2-[(phenylmethyl)oxy]benzoic acid 
• 1362818-35-6 4-bromo-5-(4-morpholinylmethyl)-2-[(phenylmethyl)oxy]-N-3-pyridinylbenzamide 
• 1362818-32-3 2-{[(4-fluorophenyl)methyl]oxy}-4-(1-methyl-1H-pyrazol-4-yl)-5-(4-morpholinylcarbonyl)-N-4-pyridazinylbenzamide 
• 1362818-29-8 2-{[(4-fluorophenyl)methyl]oxy}-4-(1-methyl-1H-pyrazol-4-yl)-5-(4-morpholinylcarbonyl)-N-3-pyridinylbenzamide 

Relevant academic research and scientific papers

PYRIDINE DERIVATIVES AS TMEM16A MODULATORS FOR USE IN THE TREATMENT OF RESPIRATORY CONDITIONS

Compounds of general formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are as defined herein are useful for treating respiratory di

2 - (BENZYLOXY) BENZAMIDES AS LRRK2 KINASE INHIBITORS

The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by LRRK2 kinase activity, for example Parkinson's disease or Alzheimer's disease.